{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T20:25:02Z","timestamp":1786998302521,"version":"build-2736575974"},"reference-count":118,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,4]],"date-time":"2024-04-04T00:00:00Z","timestamp":1712188800000},"content-version":"am","delay-in-days":339,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R01HL 152280"],"award-info":[{"award-number":["R01HL 152280"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R01HL121294-01A1"],"award-info":[{"award-number":["R01HL121294-01A1"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["T32HL139430"],"award-info":[{"award-number":["T32HL139430"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jmmc-online.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Molecular and Cellular Cardiology"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.yjmcc.2023.03.008","type":"journal-article","created":{"date-parts":[[2023,3,23]],"date-time":"2023-03-23T17:56:45Z","timestamp":1679594205000},"page":"51-58","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Direct cardiac reprogramming: A new technology for cardiac repair"],"prefix":"10.1016","volume":"178","author":[{"given":"Paige E.","family":"Brlecic","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clark A.","family":"Bonham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Todd K.","family":"Rosengart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megumi","family":"Mathison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.yjmcc.2023.03.008_bb0005","doi-asserted-by":"crossref","first-page":"e153","DOI":"10.1161\/CIR.0000000000001052","article-title":"Heart disease and stroke Statistics-2022 update: a report from the American Heart Association","volume":"145","author":"Tsao","year":"2022","journal-title":"Circulation"},{"issue":"7","key":"10.1016\/j.yjmcc.2023.03.008_bb0010","article-title":"Global epidemiology of ischemic heart disease: results from the global burden of disease study","volume":"12","author":"Khan","year":"2020","journal-title":"Cureus"},{"key":"10.1016\/j.yjmcc.2023.03.008_bb0015","author":"C.f.D.C.A. Prevention"},{"issue":"5","key":"10.1016\/j.yjmcc.2023.03.008_bb0020","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.amjms.2020.02.004","article-title":"Estimating the economic burden of acute myocardial infarction in the US: 12 year National Data","volume":"359","author":"Bishu","year":"2020","journal-title":"Am J Med Sci"},{"issue":"9","key":"10.1016\/j.yjmcc.2023.03.008_bb0025","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1242\/dev.060897","article-title":"Extensive scar formation and regression during heart regeneration after cryoinjury in zebrafish","volume":"138","author":"Gonzalez-Rosa","year":"2011","journal-title":"Development"},{"issue":"4","key":"10.1016\/j.yjmcc.2023.03.008_bb0030","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1002\/j.2040-4603.2015.tb00658.x","article-title":"Physiological implications of myocardial scar structure","volume":"5","author":"Richardson","year":"2015","journal-title":"Compr. Physiol."},{"key":"10.1016\/j.yjmcc.2023.03.008_bb0035","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2020.594226","article-title":"Cardiomyocyte proliferation and maturation: two sides of the same coin for heart regeneration","volume":"8","author":"Zhao","year":"2020","journal-title":"Front. Cell. Dev. Biol."},{"issue":"8","key":"10.1016\/j.yjmcc.2023.03.008_bb0040","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1038\/cr.2017.91","article-title":"Cardiomyocyte proliferation: remove brakes and push accelerators","volume":"27","author":"He","year":"2017","journal-title":"Cell Res."},{"issue":"6A","key":"10.1016\/j.yjmcc.2023.03.008_bb0045","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1111\/j.1582-4934.2008.00439.x","article-title":"Features of cardiomyocyte proliferation and its potential for cardiac regeneration","volume":"12","author":"van Amerongen","year":"2008","journal-title":"J. Cell. Mol. Med."},{"issue":"10","key":"10.1016\/j.yjmcc.2023.03.008_bb0050","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1161\/01.RES.0000020201.44772.67","article-title":"Cardiomyocyte cell cycle regulation","volume":"90","author":"Pasumarthi","year":"2002","journal-title":"Circ. Res."},{"issue":"4","key":"10.1016\/j.yjmcc.2023.03.008_bb0055","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1002\/j.2040-4603.2015.tb00664.x","article-title":"Pathophysiology of myocardial infarction","volume":"5","author":"Frangogiannis","year":"2015","journal-title":"Compr. Physiol."},{"issue":"6","key":"10.1016\/j.yjmcc.2023.03.008_bb0060","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1161\/CIRCRESAHA.115.306565","article-title":"Cardiac fibrosis: the fibroblast awakens","volume":"118","author":"Travers","year":"2016","journal-title":"Circ. Res."},{"issue":"3","key":"10.1016\/j.yjmcc.2023.03.008_bb0065","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1172\/JCI31044","article-title":"ECM remodeling in hypertensive heart disease","volume":"117","author":"Berk","year":"2007","journal-title":"J. Clin. Invest."},{"issue":"4","key":"10.1016\/j.yjmcc.2023.03.008_bb0070","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/s00018-013-1349-6","article-title":"The pathogenesis of cardiac fibrosis","volume":"71","author":"Kong","year":"2014","journal-title":"Cell. Mol. Life Sci."},{"issue":"1","key":"10.1016\/j.yjmcc.2023.03.008_bb0075","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/nrcardio.2012.158","article-title":"Myofibroblast-mediated mechanisms of pathological remodelling of the heart","volume":"10","author":"Weber","year":"2013","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.yjmcc.2023.03.008_bb0080","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.yjmcc.2022.08.004","article-title":"The heart of cardiac reprogramming: the cardiac fibroblasts","volume":"172","author":"Ricketts","year":"2022","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"8","key":"10.1016\/j.yjmcc.2023.03.008_bb0085","first-page":"1097","article-title":"Donor selection in heart transplantation","volume":"6","author":"Kilic","year":"2014","journal-title":"J. Thorac Dis."},{"issue":"9","key":"10.1016\/j.yjmcc.2023.03.008_bb0090","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.tips.2015.06.004","article-title":"Novel therapeutics in myocardial infarction: targeting microvascular dysfunction and reperfusion injury","volume":"36","author":"Fordyce","year":"2015","journal-title":"Trends Pharmacol. Sci."},{"issue":"3","key":"10.1016\/j.yjmcc.2023.03.008_bb0095","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1093\/cvr\/cvu225","article-title":"ESC working group cellular biology of the heart: position paper: improving the preclinical assessment of novel cardioprotective therapies","volume":"104","author":"Lecour","year":"2014","journal-title":"Cardiovasc. Res."},{"issue":"2","key":"10.1016\/j.yjmcc.2023.03.008_bb0100","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.jacc.2014.10.031","article-title":"Remote ischemic conditioning","volume":"65","author":"Heusch","year":"2015","journal-title":"J. Am. Coll. Cardiol."},{"issue":"11","key":"10.1016\/j.yjmcc.2023.03.008_bb0105","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1038\/s41569-018-0013-0","article-title":"Cell therapy trials for heart regeneration - lessons learned and future directions","volume":"15","author":"Menasche","year":"2018","journal-title":"Nat. Rev. Cardiol."},{"issue":"2","key":"10.1016\/j.yjmcc.2023.03.008_bb0110","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.yjmcc.2010.06.010","article-title":"Cardiac cell therapy: lessons from clinical trials","volume":"50","author":"Menasche","year":"2011","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"4","key":"10.1016\/j.yjmcc.2023.03.008_bb0115","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/nrcardio.2014.9","article-title":"Cell therapy for cardiac repair--lessons from clinical trials","volume":"11","author":"Behfar","year":"2014","journal-title":"Nat. Rev. Cardiol."},{"issue":"1","key":"10.1016\/j.yjmcc.2023.03.008_bb0120","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s13287-019-1536-y","article-title":"Stem cell-derived cell sheet transplantation for heart tissue repair in myocardial infarction","volume":"11","author":"Guo","year":"2020","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/j.yjmcc.2023.03.008_bb0125","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2021.673683","article-title":"Current status and limitations of myocardial infarction large animal models in cardiovascular translational research","volume":"9","author":"Shin","year":"2021","journal-title":"Front. Bioeng. Biotechnol."},{"issue":"11 Suppl 1","key":"10.1016\/j.yjmcc.2023.03.008_bb0130","first-page":"S59","article-title":"Spatially oriented, temporally sequential smooth muscle cell-endothelial progenitor cell bi-level cell sheet neovascularizes ischemic myocardium","volume":"128","author":"Shudo","year":"2013","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.yjmcc.2023.03.008_bb0135","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.jacbts.2016.06.012","article-title":"Mitochondrial membrane permeability inhibitors in acute myocardial infarction: still awaiting translation","volume":"1","author":"Trankle","year":"2016","journal-title":"JACC Basic Transl. Sci."},{"issue":"4","key":"10.1016\/j.yjmcc.2023.03.008_bb0140","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.cell.2006.07.024","article-title":"Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors","volume":"126","author":"Takahashi","year":"2006","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.yjmcc.2023.03.008_bb0145","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.cell.2007.11.019","article-title":"Induction of pluripotent stem cells from adult human fibroblasts by defined factors","volume":"131","author":"Takahashi","year":"2007","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.yjmcc.2023.03.008_bb0150","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.cell.2010.07.002","article-title":"Direct reprogramming of fibroblasts into functional cardiomyocytes by defined factors","volume":"142","author":"Ieda","year":"2010","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.yjmcc.2023.03.008_bb0155","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.jtcvs.2016.09.041","article-title":"In situ reprogramming to transdifferentiate fibroblasts into cardiomyocytes using adenoviral vectors: implications for clinical myocardial regeneration","volume":"153","author":"Mathison","year":"2017","journal-title":"J. Thorac. Cardiovasc. Surg."},{"issue":"1","key":"10.1016\/j.yjmcc.2023.03.008_bb0160","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1159\/000345615","article-title":"Introduction to stem cells and regenerative medicine","volume":"85","author":"Kolios","year":"2013","journal-title":"Respiration"},{"issue":"6","key":"10.1016\/j.yjmcc.2023.03.008_bb0165","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1038\/s41580-021-00335-z","article-title":"Direct cell reprogramming: approaches, mechanisms and progress","volume":"22","author":"Wang","year":"2021","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"7356","key":"10.1016\/j.yjmcc.2023.03.008_bb0170","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1038\/nature10116","article-title":"Induction of functional hepatocyte-like cells from mouse fibroblasts by defined factors","volume":"475","author":"Huang","year":"2011","journal-title":"Nature"},{"issue":"7284","key":"10.1016\/j.yjmcc.2023.03.008_bb0175","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1038\/nature08797","article-title":"Direct conversion of fibroblasts to functional neurons by defined factors","volume":"463","author":"Vierbuchen","year":"2010","journal-title":"Nature"},{"issue":"1\u20132","key":"10.1016\/j.yjmcc.2023.03.008_bb0180","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.cell.2012.11.045","article-title":"Direct conversion of fibroblasts to neurons by reprogramming PTB-regulated microRNA circuits","volume":"152","author":"Xue","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.yjmcc.2023.03.008_bb0185","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.yjmcc.2013.04.004","article-title":"Optimization of direct fibroblast reprogramming to cardiomyocytes using calcium activity as a functional measure of success","volume":"60","author":"Addis","year":"2013","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"3","key":"10.1016\/j.yjmcc.2023.03.008_bb0190","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.yjmcc.2012.04.010","article-title":"A new approach to transcription factor screening for reprogramming of fibroblasts to cardiomyocyte-like cells","volume":"53","author":"Protze","year":"2012","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"6","key":"10.1016\/j.yjmcc.2023.03.008_bb0195","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.112.005652","article-title":"In vivo cardiac cellular reprogramming efficacy is enhanced by angiogenic preconditioning of the infarcted myocardium with vascular endothelial growth factor","volume":"1","author":"Mathison","year":"2012","journal-title":"J. Am. Heart Assoc."},{"issue":"1","key":"10.1016\/j.yjmcc.2023.03.008_bb0200","doi-asserted-by":"crossref","first-page":"22605","DOI":"10.1038\/s41598-021-02056-x","article-title":"Fibroblast transition to an endothelial \u201ctrans\u201d state improves cell reprogramming efficiency","volume":"11","author":"Mathison","year":"2021","journal-title":"Sci. Rep."},{"issue":"7400","key":"10.1016\/j.yjmcc.2023.03.008_bb0205","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/nature11139","article-title":"Heart repair by reprogramming non-myocytes with cardiac transcription factors","volume":"485","author":"Song","year":"2012","journal-title":"Nature"},{"issue":"7400","key":"10.1016\/j.yjmcc.2023.03.008_bb0210","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1038\/nature11044","article-title":"In vivo reprogramming of murine cardiac fibroblasts into induced cardiomyocytes","volume":"485","author":"Qian","year":"2012","journal-title":"Nature"},{"issue":"11","key":"10.1016\/j.yjmcc.2023.03.008_bb0215","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.116.003922","article-title":"MiR-590 promotes Transdifferentiation of porcine and human fibroblasts toward a cardiomyocyte-like fate by directly repressing specificity protein 1","volume":"5","author":"Singh","year":"2016","journal-title":"J. Am. Heart Assoc."},{"issue":"14","key":"10.1016\/j.yjmcc.2023.03.008_bb0220","doi-asserted-by":"crossref","first-page":"5588","DOI":"10.1073\/pnas.1301019110","article-title":"Reprogramming of human fibroblasts toward a cardiac fate","volume":"110","author":"Nam","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"4","key":"10.1016\/j.yjmcc.2023.03.008_bb0225","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.devcel.2011.03.012","article-title":"Pancreatic beta cell identity is maintained by DNA methylation-mediated repression of Arx","volume":"20","author":"Dhawan","year":"2011","journal-title":"Dev. Cell"},{"issue":"1","key":"10.1016\/j.yjmcc.2023.03.008_bb0230","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/cr.2012.175","article-title":"Embryonic stem cell and induced pluripotent stem cell: an epigenetic perspective","volume":"23","author":"Liang","year":"2013","journal-title":"Cell Res."},{"issue":"5","key":"10.1016\/j.yjmcc.2023.03.008_bb0235","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.gde.2013.07.002","article-title":"Chromatin modulators as facilitating factors in cellular reprogramming","volume":"23","author":"Luna-Zurita","year":"2013","journal-title":"Curr. Opin. Genet. Dev."},{"issue":"12","key":"10.1016\/j.yjmcc.2023.03.008_bb0240","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1038\/nmat3777","article-title":"Biophysical regulation of epigenetic state and cell reprogramming","volume":"12","author":"Downing","year":"2013","journal-title":"Nat. Mater."},{"issue":"3","key":"10.1016\/j.yjmcc.2023.03.008_bb0245","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.stemcr.2013.07.005","article-title":"Direct reprogramming of human fibroblasts toward a cardiomyocyte-like state","volume":"1","author":"Fu","year":"2013","journal-title":"Stem Cell Reports"},{"issue":"3","key":"10.1016\/j.yjmcc.2023.03.008_bb0250","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.stem.2016.02.003","article-title":"Bmi1 is a key epigenetic barrier to direct cardiac reprogramming","volume":"18","author":"Zhou","year":"2016","journal-title":"Cell Stem Cell"},{"issue":"2","key":"10.1016\/j.yjmcc.2023.03.008_bb0255","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.jtcvs.2018.03.162","article-title":"p63 silencing induces reprogramming of cardiac fibroblasts into cardiomyocyte-like cells","volume":"156","author":"Patel","year":"2018","journal-title":"J. Thorac. Cardiovasc. Surg."},{"issue":"5","key":"10.1016\/j.yjmcc.2023.03.008_bb0260","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/j.cell.2013.02.006","article-title":"Jmjd3 inhibits reprogramming by upregulating expression of INK4a\/Arf and targeting PHF20 for ubiquitination","volume":"152","author":"Zhao","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.yjmcc.2023.03.008_bb0265","doi-asserted-by":"crossref","first-page":"8243","DOI":"10.1038\/ncomms9243","article-title":"High-efficiency reprogramming of fibroblasts into cardiomyocytes requires suppression of pro-fibrotic signalling","volume":"6","author":"Zhao","year":"2015","journal-title":"Nat. Commun."},{"issue":"7259","key":"10.1016\/j.yjmcc.2023.03.008_bb0270","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1038\/nature08311","article-title":"Linking the p53 tumour suppressor pathway to somatic cell reprogramming","volume":"460","author":"Kawamura","year":"2009","journal-title":"Nature"},{"issue":"7259","key":"10.1016\/j.yjmcc.2023.03.008_bb0275","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1038\/nature08235","article-title":"Suppression of induced pluripotent stem cell generation by the p53-p21 pathway","volume":"460","author":"Hong","year":"2009","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.yjmcc.2023.03.008_bb0280","doi-asserted-by":"crossref","first-page":"E572","DOI":"10.1073\/pnas.1319743111","article-title":"Induced multipotency in adult keratinocytes through down-regulation of DeltaNp63 or DGCR8","volume":"111","author":"Chakravarti","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"6409","key":"10.1016\/j.yjmcc.2023.03.008_bb0285","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1126\/science.aau0730","article-title":"Joint profiling of chromatin accessibility and gene expression in thousands of single cells","volume":"361","author":"Cao","year":"2018","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.yjmcc.2023.03.008_bb0290","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1186\/s13059-017-1269-0","article-title":"MATCHER: manifold alignment reveals correspondence between single cell transcriptome and epigenome dynamics","volume":"18","author":"Welch","year":"2017","journal-title":"Genome Biol."},{"issue":"7719","key":"10.1016\/j.yjmcc.2023.03.008_bb0295","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1038\/s41586-018-0414-6","article-title":"RNA velocity of single cells","volume":"560","author":"La Manno","year":"2018","journal-title":"Nature"},{"issue":"29","key":"10.1016\/j.yjmcc.2023.03.008_bb0300","first-page":"1","article-title":"ATAC-seq: a method for assaying chromatin accessibility genome-wide","volume":"21","author":"Buenrostro","year":"2015","journal-title":"Curr. Protoc. Mol. Biol. 109"},{"issue":"1","key":"10.1016\/j.yjmcc.2023.03.008_bb0305","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.stem.2019.06.012","article-title":"Context-specific transcription factor functions regulate Epigenomic and transcriptional dynamics during cardiac reprogramming","volume":"25","author":"Stone","year":"2019","journal-title":"Cell Stem Cell"},{"issue":"7607","key":"10.1016\/j.yjmcc.2023.03.008_bb0310","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1038\/nature18323","article-title":"Dissecting direct reprogramming from fibroblast to neuron using single-cell RNA-seq","volume":"534","author":"Treutlein","year":"2016","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.yjmcc.2023.03.008_bb0315","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.stem.2019.05.020","article-title":"Single-cell transcriptomic analyses of cell fate transitions during human cardiac reprogramming","volume":"25","author":"Zhou","year":"2019","journal-title":"Cell Stem Cell"},{"issue":"9","key":"10.1016\/j.yjmcc.2023.03.008_bb0320","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1161\/CIRCRESAHA.112.271148","article-title":"Induction of cardiomyocyte-like cells in infarct hearts by gene transfer of Gata4, Mef2c, and Tbx5","volume":"111","author":"Inagawa","year":"2012","journal-title":"Circ. Res."},{"issue":"3","key":"10.1016\/j.yjmcc.2023.03.008_bb0325","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.stemcr.2020.07.022","article-title":"Soft matrix promotes cardiac reprogramming via inhibition of YAP\/TAZ and suppression of fibroblast signatures","volume":"15","author":"Kurotsu","year":"2020","journal-title":"Stem Cell Reports"},{"issue":"5","key":"10.1016\/j.yjmcc.2023.03.008_bb0330","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1016\/j.jtcvs.2017.06.035","article-title":"Cardiac reprogramming factor Gata4 reduces postinfarct cardiac fibrosis through direct repression of the profibrotic mediator snail","volume":"154","author":"Mathison","year":"2017","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"10.1016\/j.yjmcc.2023.03.008_bb0335","doi-asserted-by":"crossref","first-page":"38815","DOI":"10.1038\/srep38815","article-title":"Tissue-engineered 3-dimensional (3D) microenvironment enhances the direct reprogramming of fibroblasts into cardiomyocytes by microRNAs","volume":"6","author":"Li","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.yjmcc.2023.03.008_bb0340","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.semcdb.2021.05.028","article-title":"Environmental factors influence somatic cell reprogramming to cardiomyocyte-like cells","volume":"122","author":"Van Handel","year":"2022","journal-title":"Semin. Cell Dev. Biol."},{"key":"10.1016\/j.yjmcc.2023.03.008_bb0345","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1111\/j.1749-6632.2012.06696.x","article-title":"Cardiac repair with thymosin \u03b24 and cardiac reprogramming factors","volume":"1270","author":"Srivastava","year":"2012","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"10","key":"10.1016\/j.yjmcc.2023.03.008_bb0350","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1161\/CIRCULATIONAHA.116.024692","article-title":"Chemical enhancement of in vitro and in vivo direct cardiac reprogramming","volume":"135","author":"Mohamed","year":"2017","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.yjmcc.2023.03.008_bb0355","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1016\/j.jtcvs.2014.03.033","article-title":"\u201ctriplet\u201d polycistronic vectors encoding Gata4, Mef2c, and Tbx5 enhances postinfarct ventricular functional improvement compared with singlet vectors","volume":"148","author":"Mathison","year":"2014","journal-title":"J. Thorac. Cardiovasc. Surg."},{"issue":"2","key":"10.1016\/j.yjmcc.2023.03.008_bb0360","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.jtcvs.2016.09.041","article-title":"In situ reprogramming to transdifferentiate fibroblasts into cardiomyocytes using adenoviral vectors: implications for clinical myocardial regeneration","volume":"153","author":"Mathison","year":"2017","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"10.1016\/j.yjmcc.2023.03.008_bb0365","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.bbrc.2021.04.121","article-title":"Direct reprogramming with Sendai virus vectors repaired infarct hearts at the chronic stage","volume":"560","author":"Isomi","year":"2021","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.yjmcc.2023.03.008_bb0370","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1093\/cvr\/cvv223","article-title":"In vivo cardiac reprogramming using an optimal single polycistronic construct","author":"Ma","year":"2015","journal-title":"Cardiovasc. Res."},{"issue":"566","key":"10.1016\/j.yjmcc.2023.03.008_bb0375","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aay7856","article-title":"Down-regulation of Beclin1 promotes direct cardiac reprogramming","volume":"12","author":"Wang","year":"2020","journal-title":"Sci. Transl. Med."},{"issue":"1","key":"10.1016\/j.yjmcc.2023.03.008_bb0380","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.stem.2017.11.010","article-title":"Direct in vivo reprogramming with Sendai virus vectors improves cardiac function after myocardial infarction","volume":"22","author":"Miyamoto","year":"2018","journal-title":"Cell Stem Cell"},{"issue":"1","key":"10.1016\/j.yjmcc.2023.03.008_bb0385","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s41232-021-00168-5","article-title":"Cardiac regeneration by direct reprogramming in this decade and beyond","volume":"41","author":"Yamakawa","year":"2021","journal-title":"Inflamm. Regen."},{"key":"10.1016\/j.yjmcc.2023.03.008_bb0390","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.semcdb.2021.05.019","article-title":"Direct reprogramming as a route to cardiac repair","volume":"122","author":"Garry","year":"2022","journal-title":"Semin. Cell Dev. Biol."},{"issue":"3","key":"10.1016\/j.yjmcc.2023.03.008_bb0395","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1161\/CIRCRESAHA.116.304510","article-title":"MicroRNA induced cardiac reprogramming in vivo: evidence for mature cardiac myocytes and improved cardiac function","volume":"116","author":"Jayawardena","year":"2015","journal-title":"Circ. Res."},{"issue":"11","key":"10.1016\/j.yjmcc.2023.03.008_bb0400","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1161\/CIRCRESAHA.112.269035","article-title":"MicroRNA-mediated in vitro and in vivo direct reprogramming of cardiac fibroblasts to cardiomyocytes","volume":"110","author":"Jayawardena","year":"2012","journal-title":"Circ. Res."},{"key":"10.1016\/j.yjmcc.2023.03.008_bb0405","doi-asserted-by":"crossref","first-page":"3741","DOI":"10.2147\/IJN.S304873","article-title":"Highly efficient MicroRNA delivery using functionalized carbon dots for enhanced conversion of fibroblasts to cardiomyocytes","volume":"16","author":"Yang","year":"2021","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.yjmcc.2023.03.008_bb0410","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1038\/s41422-018-0036-4","article-title":"Chemical-induced cardiac reprogramming in vivo","author":"Huang","year":"2018","journal-title":"Cell Res."},{"issue":"600","key":"10.1016\/j.yjmcc.2023.03.008_bb0415","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abd6892","article-title":"Gene therapy knockdown of hippo signaling induces cardiomyocyte renewal in pigs after myocardial infarction","volume":"13","author":"Liu","year":"2021","journal-title":"Sci. Transl. Med."},{"issue":"5","key":"10.1016\/j.yjmcc.2023.03.008_bb0420","doi-asserted-by":"crossref","DOI":"10.1002\/nbm.3693","article-title":"Multiparametric CMR imaging of infarct remodeling in a percutaneous reperfused Yucatan mini-pig model","volume":"30","author":"Lopez","year":"2017","journal-title":"NMR Biomed."},{"issue":"10","key":"10.1016\/j.yjmcc.2023.03.008_bb0425","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1161\/CIRCRESAHA.120.315855","article-title":"Gene therapy for the heart lessons learned and future perspectives","volume":"126","author":"Cannat\u00e0","year":"2020","journal-title":"Circ. Res."},{"issue":"11","key":"10.1016\/j.yjmcc.2023.03.008_bb0430","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1161\/CIRCRESAHA.114.302331","article-title":"Adeno-associated virus vectors as therapeutic and investigational tools in the cardiovascular system","volume":"114","author":"Zacchigna","year":"2014","journal-title":"Circ. Res."},{"issue":"6","key":"10.1016\/j.yjmcc.2023.03.008_bb0435","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1038\/gt.2012.17","article-title":"VEGF gene therapy: therapeutic angiogenesis in the clinic and beyond","volume":"19","author":"Giacca","year":"2012","journal-title":"Gene Ther."},{"issue":"7","key":"10.1016\/j.yjmcc.2023.03.008_bb0440","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/j.jacc.2004.12.068","article-title":"Direct intramyocardial plasmid vascular endothelial growth factor-A165 gene therapy in patients with stable severe angina pectoris a randomized double-blind placebo-controlled study: the Euroinject one trial","volume":"45","author":"Kastrup","year":"2005","journal-title":"J. Am. Coll. Cardiol."},{"issue":"9 Suppl","key":"10.1016\/j.yjmcc.2023.03.008_bb0445","first-page":"I157","volume":"112","author":"Gy\u00f6ngy\u00f6si","year":"2005","journal-title":"Circulation"},{"issue":"14","key":"10.1016\/j.yjmcc.2023.03.008_bb0450","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1038\/sj.gt.3302071","article-title":"Gene therapy progress and prospects: adenoviral vectors","volume":"10","author":"St George","year":"2003","journal-title":"Gene Ther."},{"issue":"5","key":"10.1016\/j.yjmcc.2023.03.008_bb0455","doi-asserted-by":"crossref","first-page":"5918","DOI":"10.1021\/acsomega.8b00904","article-title":"Chimeric adeno-associated virus-mediated cardiovascular reprogramming for ischemic heart disease","volume":"3","author":"Yoo","year":"2018","journal-title":"ACS Omega"},{"issue":"7756","key":"10.1016\/j.yjmcc.2023.03.008_bb0460","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1038\/s41586-019-1191-6","article-title":"MicroRNA therapy stimulates uncontrolled cardiac repair after myocardial infarction in pigs","volume":"569","author":"Gabisonia","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.yjmcc.2023.03.008_bb0465","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.omtm.2017.11.007","article-title":"Emerging issues in AAV-mediated in vivo gene therapy","volume":"8","author":"Colella","year":"2018","journal-title":"Mol. Ther. Methods Clin. Dev."},{"issue":"6","key":"10.1016\/j.yjmcc.2023.03.008_bb0470","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1007\/s00109-022-02208-0","article-title":"Adenoviral vectors for cardiovascular gene therapy applications: a clinical and industry perspective","volume":"100","author":"Jt","year":"2022","journal-title":"J. Mol. Med. (Berl.)"},{"key":"10.1016\/j.yjmcc.2023.03.008_bb0475","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.biomaterials.2018.11.034","article-title":"Efficient in vivo direct conversion of fibroblasts into cardiomyocytes using a nanoparticle-based gene carrier","volume":"192","author":"Chang","year":"2019","journal-title":"Biomaterials"},{"issue":"2","key":"10.1016\/j.yjmcc.2023.03.008_bb0480","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.apsb.2019.09.003","article-title":"Lineage reprogramming of fibroblasts into induced cardiac progenitor cells by CRISPR\/Cas9-based transcriptional activators","volume":"10","author":"Wang","year":"2020","journal-title":"Acta Pharm. Sin. B"},{"issue":"1","key":"10.1016\/j.yjmcc.2023.03.008_bb0485","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.ymthe.2021.10.015","article-title":"CRISPR activation of endogenous genes reprograms fibroblasts into cardiovascular progenitor cells for myocardial infarction therapy","volume":"30","author":"Jiang","year":"2022","journal-title":"Mol. Ther."},{"issue":"7536","key":"10.1016\/j.yjmcc.2023.03.008_bb0490","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/nature14136","article-title":"Genome-scale transcriptional activation by an engineered CRISPR-Cas9 complex","volume":"517","author":"Konermann","year":"2015","journal-title":"Nature"},{"issue":"10","key":"10.1016\/j.yjmcc.2023.03.008_bb0495","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0223842","article-title":"Induced cardiomyocyte maturation: cardiac transcription factors are necessary but not sufficient","volume":"14","author":"Dal-Pra","year":"2019","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.yjmcc.2023.03.008_bb0500","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1016\/j.apsb.2021.05.020","article-title":"In vivo delivery of CRISPR-Cas9 therapeutics: Progress and challenges","volume":"11","author":"Behr","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"issue":"7","key":"10.1016\/j.yjmcc.2023.03.008_bb0505","doi-asserted-by":"crossref","first-page":"813","DOI":"10.4244\/EIJV6I7A140","article-title":"A randomised, double-blind, placebo-controlled, multicentre study of the safety and efficacy of BIOBYPASS (AdGVVEGF121.10NH) gene therapy in patients with refractory advanced coronary artery disease: the NOVA trial","volume":"6","author":"Kastrup","year":"2011","journal-title":"EuroIntervention"},{"issue":"3","key":"10.1016\/j.yjmcc.2023.03.008_bb0510","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.yjmcc.2007.09.012","article-title":"Comparison of intracoronary and transendocardial delivery of allogeneic mesenchymal cells in a canine model of acute myocardial infarction","volume":"44","author":"Perin","year":"2008","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"11 Suppl 1","key":"10.1016\/j.yjmcc.2023.03.008_bb0515","first-page":"S42","article-title":"Comparison of transendocardial and intracoronary CD34+ cell transplantation in patients with nonischemic dilated cardiomyopathy","volume":"128","author":"Vrtovec","year":"2013","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.yjmcc.2023.03.008_bb0520","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1253\/circj.CJ-09-0594","article-title":"Myocardial transfection of hypoxia inducible factor-1alpha via an adenoviral vector during coronary artery bypass grafting. - a multicenter phase I and safety study","volume":"74","author":"Kilian","year":"2010","journal-title":"Circ. J."},{"issue":"5","key":"10.1016\/j.yjmcc.2023.03.008_bb0525","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1161\/01.CIR.100.5.468","article-title":"Angiogenesis gene therapy: phase I assessment of direct intramyocardial administration of an adenovirus vector expressing VEGF121 cDNA to individuals with clinically significant severe coronary artery disease","volume":"100","author":"Rosengart","year":"1999","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.yjmcc.2023.03.008_bb0530","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1038\/mt.2013.13","article-title":"Mechanistic, technical, and clinical perspectives in therapeutic stimulation of coronary collateral development by angiogenic growth factors","volume":"21","author":"Rubanyi","year":"2013","journal-title":"Mol. Ther."},{"key":"10.1016\/j.yjmcc.2023.03.008_bb0535","doi-asserted-by":"crossref","first-page":"5352","DOI":"10.1016\/j.ijcard.2013.08.004","article-title":"Complications of transseptal catheterization for different cardiac procedures","volume":"2013","author":"Katritsis","year":"2013","journal-title":"Int. J. Cardiol."},{"issue":"9365","key":"10.1016\/j.yjmcc.2023.03.008_bb0540","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1016\/S0140-6736(03)12978-9","article-title":"Silent and apparent cerebral embolism after retrograde catheterisation of the aortic valve in valvular stenosis: a prospective, randomised study","volume":"361","author":"Omran","year":"2003","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.yjmcc.2023.03.008_bb0545","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.ahj.2004.05.031","article-title":"Should we cross the valve: the risk of retrograde catheterization of the left ventricle in patients with aortic stenosis","volume":"148","author":"Meine","year":"2004","journal-title":"Am. Heart J."},{"issue":"4","key":"10.1016\/j.yjmcc.2023.03.008_bb0550","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/j.jtcvs.2007.09.073","article-title":"Concomitant treatment with oral L-arginine improves the efficacy of surgical angiogenesis in patients with severe diffuse coronary artery disease: the endothelial modulation in Angiogenic therapy randomized controlled trial","volume":"135","author":"Ruel","year":"2008","journal-title":"J. Thorac. Cardiovasc. Surg."},{"issue":"4","key":"10.1016\/j.yjmcc.2023.03.008_bb0555","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/0735-1097(95)00280-4","article-title":"Recurrence of angina after coronary artery bypass surgery: predictors and prognosis (CASS registry). Coronary Artery Surgery Study","volume":"26","author":"Cameron","year":"1995","journal-title":"J. Am. Coll. Cardiol."},{"issue":"2","key":"10.1016\/j.yjmcc.2023.03.008_bb0560","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0022-5223(96)70243-X","article-title":"The importance of completeness of revascularization during long-term follow-up after coronary artery operations","volume":"112","author":"Jones","year":"1996","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"10.1016\/j.yjmcc.2023.03.008_bb0565","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.amjcard.2020.06.047","article-title":"Incidence and prognostic impact of incomplete revascularization documented by coronary angiography 1 year after coronary artery bypass grafting","volume":"131","author":"Hattler","year":"2020","journal-title":"Am. J. Cardiol."},{"issue":"1","key":"10.1016\/j.yjmcc.2023.03.008_bb0570","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1253\/circj.CJ-18-0653","article-title":"Impact of complete revascularization on long-term outcomes after coronary artery bypass grafting in patients with left ventricular dysfunction","volume":"83","author":"Lee","year":"2018","journal-title":"Circ. J."},{"issue":"1","key":"10.1016\/j.yjmcc.2023.03.008_bb0575","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.jtcvs.2010.07.094","article-title":"Complex coronary anatomy in coronary artery bypass graft surgery: impact of complex coronary anatomy in modern bypass surgery? Lessons learned from the SYNTAX trial after two years","volume":"141","author":"Mohr","year":"2011","journal-title":"J. Thorac. Cardiovasc. Surg."},{"issue":"5","key":"10.1016\/j.yjmcc.2023.03.008_bb0580","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1093\/icvts\/ivu012","article-title":"A meta-analysis of adjusted risk estimates for survival from observational studies of complete versus incomplete revascularization in patients with multivessel disease undergoing coronary artery bypass grafting","volume":"18","author":"Takagi","year":"2014","journal-title":"Interact. Cardiovasc. Thorac. Surg."},{"issue":"3","key":"10.1016\/j.yjmcc.2023.03.008_bb0585","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/s41569-020-00457-5","article-title":"Complete versus incomplete coronary revascularization: definitions, assessment and outcomes","volume":"18","author":"Gaba","year":"2021","journal-title":"Nat. Rev. Cardiol."},{"issue":"2","key":"10.1016\/j.yjmcc.2023.03.008_bb0590","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1002\/ejhf.446","article-title":"Direct cellular reprogramming for cardiac repair and regeneration","volume":"18","author":"Batty","year":"2016","journal-title":"Eur. J. Heart Fail."}],"container-title":["Journal of Molecular and Cellular Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022282823000536?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022282823000536?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T20:38:07Z","timestamp":1758314287000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022282823000536"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":118,"alternative-id":["S0022282823000536"],"URL":"https:\/\/doi.org\/10.1016\/j.yjmcc.2023.03.008","relation":{},"ISSN":["0022-2828"],"issn-type":[{"value":"0022-2828","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Direct cardiac reprogramming: A new technology for cardiac repair","name":"articletitle","label":"Article Title"},{"value":"Journal of Molecular and Cellular Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yjmcc.2023.03.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}